Richard B Pollard
Overview
Explore the profile of Richard B Pollard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2777
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sainz T, Serrano-Villar S, Mann S, Ma Z, Utay N, Thompson C, et al.
AIDS
. 2019 Nov;
33(15):2289-2298.
PMID: 31764094
Background: We aimed to characterize the impact of antiretroviral therapy (ART) initiation on gastrointestinal-associated lymphoid tissue at various sites along the gastrointestinal site. Methodology: Peripheral blood and duodenal and rectal...
2.
Matassoli F, Leao I, Bezerra B, Pollard R, Lutjohann D, Hildreth J, et al.
mSphere
. 2018 Nov;
3(6).
PMID: 30404938
Monocytes from HIV-infected patients produce increased levels of inflammatory cytokines, which are associated with chronic immune activation and AIDS progression. Chronic immune activation is often not restored even in patients...
3.
George V, Harrison L, Roach M, Li X, Tierney C, Fischl M, et al.
J Infect Dis
. 2017 Oct;
216(9):1159-1163.
PMID: 29040604
A nested case-cohort study was performed in participants of a clinical trial of first-line human immunodeficiency virus treatments to investigate plasma biomarkers of inflammation and microbial translocation for their association...
4.
Asmuth D, Thompson C, Chun T, Ma Z, Mann S, Sainz T, et al.
J Infect Dis
. 2017 Oct;
216(7):813-818.
PMID: 28968888
Plasma, duodenal, and rectal tissue antiretroviral therapy (ART) drug concentrations, human immunodeficiency virus (HIV) RNA and HIV DNA copy numbers, and recovery of mucosal immunity were measured before and 9...
5.
Serrano-Villar S, Sainz T, Ma Z, Utay N, Wook-Chun T, Mann S, et al.
PLoS Pathog
. 2017 May;
13(5):e1006368.
PMID: 28467485
[This corrects the article DOI: 10.1371/journal.ppat.1005381.].
6.
Serrano-Villar S, Sainz T, Ma Z, Utay N, Chun T, Mann S, et al.
PLoS Pathog
. 2016 Mar;
12(3):e1005540.
PMID: 27015639
No abstract available.
7.
Serrano-Villar S, Sainz T, Ma Z, Utay N, Chun T, Wook-Chun T, et al.
PLoS Pathog
. 2016 Jan;
12(1):e1005381.
PMID: 26795282
Whether initiation of antiretroviral therapy (ART) regimens aimed at achieving greater concentrations within gut associated lymphoid tissue (GALT) impacts the level of mucosal immune reconstitution, inflammatory markers and the viral...
8.
Asmuth D, Utay N, Pollard R
Expert Opin Investig Drugs
. 2015 Dec;
25(2):249-57.
PMID: 26667398
Introduction: Novel approaches are urgently needed to achieve the next level of control of HIV infection beyond antiretroviral medications that will lead to the ultimate goal of curing HIV infection....
9.
Balagopal A, Asmuth D, Yang W, Campbell T, Gupte N, Smeaton L, et al.
J Acquir Immune Defic Syndr
. 2015 May;
70(2):163-71.
PMID: 26017661
Background: Despite the success of combination antiretroviral therapy (cART), a subset of HIV-infected patients who initiate cART develop early clinical progression to AIDS; therefore, some cART initiators are not fully...
10.
Tenforde M, Gupte N, Dowdy D, Asmuth D, Balagopal A, Pollard R, et al.
PLoS One
. 2015 Feb;
10(2):e0117424.
PMID: 25719208
Objective: The association between pre-antiretroviral (ART) inflammation and immune activation and risk for incident tuberculosis (TB) after ART initiation among adults is uncertain. Design: Nested case-control study (n = 332)...